MoonLake Immunotherapeutics - Class A (MLTX) Earnings Report - Forecasts and Surprise Ratio

Quarterly Earnings History

Date of next report: Aug 8, 2024

Estimate for Q2 24: $-0.27

Implied change from Q1 24: +22.73%

Implied change from Q2 23: +17.39%

Earnings Period	Date Reported	EPS / Forecast	Surprise
Q1 24	May 7, 2024	$-0.22 / $-0.21	$-0.01 / -4.76%
Q4 23	Feb 29, 2024	$-0.12 / $-0.21	$0.09 / 42.86%
Q3 23	Nov 14, 2023	$-0.18 / $-0.22	$0.04 / 18.18%
Q2 23	Aug 10, 2023	$-0.23 / $-0.25	$0.02 / 8%
Q1 23	May 12, 2023	$-0.23 / $-0.28	$0.05 / 17.86%
Q4 22	Mar 20, 2023	$-0.31 / $-0.32	$0.01 / 3.12%
Q3 22	Nov 14, 2022	$-0.27 / $-0.32	$0.05 / 15.63%
Q2 22	Aug 12, 2022	$-0.34 / $-	$0 / -

Data Vendor: Xignite Logo